✦ LIBER ✦

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status

✍ Scribed by B. L. Langdahl; F. Marin; E. Shane; H. Dobnig; J. R. Zanchetta; M. Maricic; K. Krohn; K. See; M. R. Warner

Book ID: 105864647
Publisher: Springer-Verlag
Year: 2009
Tongue: English
Weight: 225 KB
Volume: 20
Category: Article
ISSN: 0937-941X
DOI: 10.1007/s00198-009-0917-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teriparatide versus alendronate for trea

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Effects of gender and menopausal status — 24-month results

✍ H. Dobnig; M.R. Warner; B.L. Langdahl; R. Möricke; K. See; F. Marin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Teriparatide versus alendronate for trea

Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Effects of gender and menopausal status — 24-month results

✍ H. Dobnig; M.R. Warner; B.L. Langdahl; R. Möricke; K. See; F. Marin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Effects of teriparatide versus alendrona

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six–month results of a randomized, double-blind, controlled trial

✍ Kenneth G. Saag; Jose R. Zanchetta; Jean-Pierre Devogelaer; Robert A. Adler; Ric 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective To compare the bone anabolic drug teriparatide (20 μg/day) with the antiresorptive drug alendronate (10 mg/day) for treating glucocorticoid‐induced osteoporosis (OP). ## Methods This was a 36‐month, randomized, double‐blind, controlled trial in 428 subjects with OP (ages